Max Robotics — Global Service Robot Directory + US Certification

About

In Ho Chang is a urologic surgeon and researcher whose work focuses on improving outcomes for patients with urologic cancers, particularly prostate and kidney cancers. His research spans the impact of postoperative complications on cancer prognosis, the refinement of surgical techniques to enhance quality of life, and the application of robotic surgery for rare tumors. A key contribution is his 2023 population-based study (8 citations) demonstrating that urinary tract infections following radical prostatectomy or radiation therapy significantly worsen the prognosis of prostate cancer patients, highlighting the critical need for infection prevention in survivorship care. Chang also led a 2024 systematic review and meta-analysis (3 citations) showing that bladder neck sparing during robotic-assisted radical prostatectomy improves early continence recovery without compromising cancer control, offering a valuable technical refinement. Additionally, he reported the first robotic-assisted partial nephrectomy for a juxtaglomerular cell tumor (reninoma) in 2019 (3 citations), successfully treating a rare cause of secondary hypertension. Through these contributions, Chang advances both the safety and functional outcomes of minimally invasive urologic oncology.